-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : BMO CUTS TARGET PRICE TO $290 FROM $318

Reuters·10/30/2026 10:53:03

Please log in to view news